Sign Up to like & get
recommendations!
0
Published in 2025 at "Gastric Cancer"
DOI: 10.1007/s10120-025-01609-7
Abstract: Temporal and spatial molecular heterogeneity contributes to resistance to targeted and immune therapies in gastric and esophagogastric junction carcinoma (G/EGJ). This study evaluates differences in biomarker expression between primary G/EGJ and paired peritoneal metastases (PM).…
read more here.
Keywords:
junction carcinoma;
biomarker;
primary egj;
biomarker expression ... See more keywords